Paroxysmal nocturnal haemoglobinuria (PNH)
Bedside summary
An acquired clonal stem-cell disorder causing complement-mediated intravascular haemolysis, thrombosis (often at unusual sites) and a degree of marrow failure. Presents with dark morning urine, anaemia, abdominal/back pain, and — the leading cause of death — venous thrombosis, classically Budd-Chiari (hepatic vein) or cerebral/abdominal veins. Overlaps with aplastic anaemia.
Red flags
- Abdominal pain + ascites / deranged LFTs — Budd-Chiari (hepatic vein thrombosis)
- Headache, seizure or focal deficit — cerebral venous sinus thrombosis
- Severe symptomatic anaemia / haemoglobinuria
- New thrombosis at any unusual site
- Fever during haemolysis — infection-triggered crisis
Assessment
Differential diagnosis
- Other intravascular haemolysis — G6PD, autoimmune haemolytic anaemia, mechanical (valve), microangiopathy (TTP/HUS/DIC)
- Aplastic anaemia / MDS (overlap)
- Provoked/unprovoked thrombosis of other cause
- Rhabdomyolysis / myoglobinuria (red urine, no red cells)
- Transfusion reaction
- Wilson disease / other haemolytic crises
Investigations
- FBC + reticulocytes + film; LDH markedly raised, haptoglobin low, unconjugated bilirubin up
- Direct antiglobulin test (DAT/Coombs) NEGATIVE (non-immune haemolysis)
- Urinalysis — haemoglobinuria (blood positive, few/no red cells); urinary haemosiderin
- FLOW CYTOMETRY for GPI-deficient cells (FLAER) — the diagnostic test
- D-dimer/imaging if thrombosis suspected (Doppler, CT/MR venography for Budd-Chiari/cerebral veins)
- U&E, LFTs; iron studies (chronic urinary iron loss)
Management
- Recognise Coombs-NEGATIVE intravascular haemolysis with thrombosis and confirm by flow cytometry
- Treat/anticoagulate thrombosis promptly — it is the main killer (e.g. Budd-Chiari, cerebral venous sinus)
- Supportive care: transfuse for symptomatic anaemia, folic acid, iron for urinary losses
- Urgent haematology referral — definitive therapy is complement inhibition (eculizumab / ravulizumab)
- Ensure meningococcal vaccination/prophylaxis before/around starting a complement inhibitor
- Treat infection promptly (it triggers haemolytic exacerbations)
- Manage marrow-failure overlap as for aplastic anaemia if pancytopenic
Drugs & doses
Disposition
Complications & pitfalls
- Venous thrombosis at unusual sites (leading cause of death)
- Renal impairment (chronic haemoglobinuria)
- Pulmonary hypertension
- Progression to aplastic anaemia / MDS / AML
- Meningococcal sepsis on complement inhibitors
Exam pearls
- Coombs-NEGATIVE intravascular haemolysis + thrombosis (esp. Budd-Chiari) should trigger PNH testing by flow cytometry
- Thrombosis — not anaemia — is what kills; anticoagulate promptly and have a low threshold to image unusual sites
- Vaccinate against meningococcus before starting a complement inhibitor and give antibiotic cover
- Chronic urinary iron loss means these patients can be iron-deficient despite haemolysis
PNH thrombosis (classically Budd-Chiari or cerebral venous) is the leading cause of death — anticoagulate promptly and refer for complement inhibition (with prior meningococcal cover). Antibiotic doses per BNF (current edition); confirm choice in the in-app Antibiotic Dosing tool.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.